A Chronicle Pharmabiz Special
October 25, 2007
Chem show set to sweep Mumbai
It seems that Chem Expo / Pharma Expo has become the buzzword of the growing chemical and pharmaceutical industry. And the roaring Mumbai metro is about to hearken the chants of advanced technologies in these segments soon
"Pharma Expo will address growing needs of industry"
The Confederation of Indian Industry (CII) works to create and sustain an environment conducive to the growth of industry in India, partnering industry and government alike through advisory and consultative processes.
Fine chems poised for a leap
Fine and special chemicals are defined as expensive chemical products that are made in relatively small quantities. These chemicals are also known for their high cost (e.g. a flavouring or vitamin).
Chiral drugs: The perennial lure
Presently, almost 20 million chemical compounds are known and a number of them are isomers. Isomers are compounds with identical molecular formulas. But they differ in the nature of the sequence of the bonding of their atoms in space.
Quality agreement for API suppliers
The regulatory landscape for pharmaceutical manufacturers has been modified recently by additional US Food and Drug Administration (FDA) guidance that makes quality agreements
Statins: A great opportunity
Statins are a class of drugs that lowers the level of cholesterol in the blood by reducing the production of cholesterol by the liver. These are hypolipidemic agents, used as pharmaceutical ingredients to lower cholesterol levels
EU fine chemicals group seeks standards for excipients
The European Fine Chemicals Group (EFCG), a CEFIC sector group representing 37 European-based fine chemicals companies and nine national associations, demanded standards for excipients used in pharmaceutical manufacturing
Fluorine compounds surge
There has been a huge amount of interest in the production of fluorinated molecules with applications in the pharmaceuticals and agrochemicals fields in recent years.
Indian drug makers bet on generic boom
The aggressive Indian bulk drug manufacturers could enjoy a better part of business in the global pharma market as providers of raw materials for the overseas clients in the fast growing drug industry.
Flow chemistry for pharma firms
In recent years, a confluence of spectacular advances in chemistry, molecular biology, genomic and chemical technology, synthesis and the cognate fields of spectroscopy, chromatography and crystallography